Development impact analysis of gemtuzumab ozogamicin for the treatment of CD33-positive acute myeloid leukemia
Kelly A. Reynolds,Daniel I. Schlessinger,Arianna F. Yanes, V. Godinez-Puig,Brian R. Chen,Anastasia O. Kurta, J. K. Cotseones,S. G. Chiren,Sanjana Iyengar,Sarah A. Ibrahim,Bianca Y. Kang,Brandon Worley,Ramona Behshad,Danielle M. DeHoratius,Pablo Denes,Aaron M. Drucker, Leonard M. Dzubow,Jeremy R. Etzkorn,Catherine A. Harwood,John Y.S. Kim,Naomi Lawrence,Erica H. Lee,Gary S. Lissner, A.A. Marghoob,Rubeta N Matin,Adam R. Mattox,Bharat B. Mittal,J. R. Thomas,Xiaolong Alan Zhou,David Zloty,Brett G.M. Hughes, Michelle K. Nottage,Adèle C Green, A. Testori,Giuseppe Argenziano,Caterina Longo,Iris Zalaudek,Céleste Lebbé, Joseph Malvehy,Philippe Saiag, S. S. Cernea,Jochen Schmitt,Jamie J Kirkham,Emily Poon,Joseph F. Sobanko,Todd V. Cartee,Ian A. Maher,Murad Alam British Journal of Dermatology(2020)
AI 理解论文
溯源树
样例